Conference Details

The Somaliland Medical Association (SLMA) held a consultative and information-sharing meeting with the Drug Importers and Wholesalers Association (DIWA) as part of its ongoing efforts to promote patient safety, strengthen the healthcare system, and improve access to safe, effective, and high-quality medicines across Somaliland.

The meeting brought together representatives from both organizations to discuss key issues affecting the pharmaceutical sector and to explore practical ways of strengthening collaboration between healthcare professionals and pharmaceutical importers. Discussions focused on improving the quality of medicines imported into the country, enhancing regulatory compliance, and ensuring that patients have access to safe and reliable pharmaceutical products.

A central theme of the meeting was the prevention of counterfeit, substandard, and falsified medicines, which continue to pose significant risks to public health worldwide. Participants exchanged views on the challenges facing the pharmaceutical supply chain and emphasized the need for stronger mechanisms to monitor, verify, and maintain the quality of medicines entering and circulating within the country.

Both SLMA and DIWA highlighted the importance of establishing and maintaining robust quality assurance systems throughout the pharmaceutical supply chain, including procurement, importation, storage, transportation, and distribution. They stressed that adherence to recognized quality standards is essential for protecting patients and maintaining public confidence in healthcare services.

The meeting also underscored the importance of public awareness and health education. Participants discussed the need to educate communities on the safe and appropriate use of medicines, the dangers of purchasing medicines from unauthorized sources, and the importance of seeking medical advice from qualified healthcare professionals.

Furthermore, both organizations recognized that safeguarding medicine quality is a shared responsibility requiring close cooperation among healthcare professionals, pharmaceutical importers, pharmacists, regulatory authorities, policymakers, and other stakeholders. They agreed that stronger partnerships and regular engagement are vital for addressing challenges within the pharmaceutical sector and advancing public health objectives.

The meeting concluded with a mutual commitment to continue collaboration and dialogue on matters related to medicine quality, patient safety, pharmaceutical regulation, and healthcare system strengthening. Both the Somaliland Medical Association (SLMA) and the Drug Importers and Wholesalers Association (DIWA) reaffirmed their dedication to supporting initiatives that ensure the availability of safe, effective, and affordable medicines for the people of Somaliland.